T. G. Kapp, F. Rechenmacher, S. Neubauer, O. V. Maltsev, E. A. Cavalcanti-adam et al., A comprehensive evaluation of the activity and selectivity profile of ligands for rgd-binding integrins, vol.7, p.39805, 2017.

R. Stupp, M. E. Hegi, T. Gorlia, S. C. Erridge, J. Perry et al., European Organisation for, C. Treatment of, C. Canadian Brain Tumor, C.s. team, Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, Lancet Oncol, vol.15, issue.10, pp.1100-1108, 2014.

A. R. Reynolds, I. R. Hart, A. R. Watson, J. C. Welti, R. G. Silva et al., Stimulation of tumor growth and angiogenesis by low concentrations of RGDmimetic integrin inhibitors, Nat. Med, vol.15, issue.4, pp.392-400, 2009.

L. Di-blasio, S. Droetto, J. Norman, F. Bussolino, and L. Primo, Protein kinase D1 regulates VEGF-A-induced alphavbeta3 integrin trafficking and endothelial cell migration, Traffic, vol.11, issue.8, pp.1107-1118, 2010.

F. Ruffini, G. Graziani, L. Levati, L. Tentori, S. D'atri et al., Cilengitide downmodulates invasiveness and vasculogenic mimicry of neuropilin 1 expressing melanoma cells through the inhibition of alphavbeta5 integrin, Int. J. Canc, vol.136, issue.6, pp.545-558, 2015.

S. Koch, S. Tugues, X. Li, L. Gualandi, and L. Claesson-welsh, Signal transduction by vascular endothelial growth factor receptors, Biochem. J, vol.437, issue.2, pp.169-183, 2011.

Q. Shi and D. Boettiger, A novel mode for integrin-mediated signaling: tethering is required for phosphorylation of FAK Y397, Mol. Biol. Cell, vol.14, issue.10, pp.4306-4315, 2003.

S. Miyamoto, H. Teramoto, O. A. Coso, J. S. Gutkind, P. D. Burbelo et al., Integrin function: molecular hierarchies of cytoskeletal and signaling molecules, J. Cell Biol, vol.131, issue.3, pp.791-805, 1995.

L. Fourel, A. Valat, E. Faurobert, R. Guillot, I. Bourrin-reynard et al., Albiges-Rizo, beta3 integrin-mediated spreading induced by matrix-bound BMP-2 controls Smad signaling in a stiffness-independent manner, J. Cell Biol, vol.212, issue.6, pp.693-706, 2016.

P. J. Keely, Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion, J. Mammary Gland. Biol. Neoplasia, vol.16, issue.3, pp.205-219, 2011.

P. M. Kaminsky, N. W. Keiser, Z. Yan, D. C. Lei-butters, and J. F. Engelhardt, Directing integrin-linked endocytosis of recombinant AAV enhances productive FAKdependent transduction, Mol. Ther, vol.20, issue.5, pp.972-983, 2012.

Z. He and M. Tessier-lavigne, Neuropilin is a receptor for the axonal chemorepellent Semaphorin III, Cell, vol.90, issue.4, pp.739-751, 1997.

A. L. Kolodkin, D. V. Levengood, E. G. Rowe, Y. T. Tai, R. J. Giger et al., Neuropilin is a semaphorin III receptor, Cell, vol.90, issue.4, pp.753-762, 1997.

S. Soker, S. Takashima, H. Q. Miao, G. Neufeld, and M. Klagsbrun, Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor, Cell, vol.92, issue.6, pp.735-745, 1998.

H. Q. Miao, P. Lee, H. Lin, S. Soker, and M. Klagsbrun, Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression, FASEB J, vol.14, issue.15, pp.2532-2539, 2000.

A. M. Jubb, L. A. Strickland, S. D. Liu, J. Mak, M. Schmidt et al., Neuropilin-1 expression in cancer and development, J. Pathol, vol.226, issue.1, pp.50-60, 2012.

S. Koch, L. A. Van-meeteren, E. Morin, C. Testini, S. Westrom et al., NRP1 presented in trans to the endothelium arrests VEGFR2 endocytosis, preventing angiogenic signaling and tumor initiation, Dev. Cell, vol.28, issue.6, pp.633-646, 2014.

S. Soker, H. Q. Miao, M. Nomi, S. Takashima, and M. Klagsbrun, VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding, J. Cell Biochem, vol.85, issue.2, pp.357-368, 2002.

G. J. Prud'homme and Y. Glinka, Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity, Oncotarget, vol.3, issue.9, pp.921-939, 2012.

R. Soldi, S. Mitola, M. Strasly, P. Defilippi, G. Tarone et al., Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2, EMBO J, vol.18, issue.4, pp.882-892, 1999.

S. D. Robinson, L. E. Reynolds, V. Kostourou, A. R. Reynolds, R. G. Silva et al., Alphav beta3 integrin limits the contribution of neuropilin-1 to vascular endothelial growth factorinduced angiogenesis, J. Biol. Chem, vol.284, issue.49, pp.33966-33981, 2009.

A. R. Reynolds, L. E. Reynolds, T. E. Nagel, J. C. Lively, S. D. Robinson et al., Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice, Cancer Res, vol.64, issue.23, pp.8643-8650, 2004.

S. D. Robinson and K. M. Hodivala-dilke, The role of beta3-integrins in tumor angiogenesis: context is everything, vol.23, pp.630-637, 2011.

C. Raimondi, J. T. Brash, A. Fantin, and C. Ruhrberg, NRP1 function and targeting in neurovascular development and eye disease, Prog. Retin Eye Res, vol.52, pp.64-83, 2016.

T. S. Ellison, S. J. Atkinson, V. Steri, B. M. Kirkup, M. E. Preedy et al., Suppression of beta3-integrin in mice triggers a neuropilin-1-dependent change in focal adhesion remodelling that can be targeted to block pathological angiogenesis, Dis. Model Mech, vol.8, issue.9, pp.1105-1119, 2015.

S. Zanella, M. Mingozzi, A. Corso, R. Fanelli, D. Arosio et al., Synthesis, characterization, and biological evaluation of a dual-action ligand targeting alphavbeta3 integrin and VEGF receptors, ChemistryOpen, vol.4, issue.5, pp.633-641, 2015.

N. Papo, A. P. Silverman, J. L. Lahti, and J. R. Cochran, Antagonistic VEGF variants engineered to simultaneously bind to and inhibit VEGFR2 and alphavbeta3 integrin, Proc. Natl. Acad. Sci. USA, vol.108, issue.34, pp.14067-14072, 2011.

E. E. Kamarulzaman, R. Vanderesse, A. M. Gazzali, M. Barberi-heyob, C. Boura et al., Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting Neuropilin-1 for anticancer application, J. Biomol. Struct. Dyn, pp.1-49, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01309306

D. Zanuy, R. Kotla, R. Nussinov, T. Teesalu, K. N. Sugahara et al., Sequence dependence of C-end rule peptides in binding and activation of neuropilin-1 receptor, J. Struct. Biol, vol.182, issue.2, pp.78-86, 2013.

T. Teesalu, K. N. Sugahara, V. R. Kotamraju, and E. Ruoslahti, C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration, Proc. Natl. Acad. Sci. USA, vol.106, issue.38, pp.16157-16162, 2009.

G. Y. Perret, A. Starzec, N. Hauet, J. Vergote, M. L. Pecheur et al., In vitro evaluation and biodistribution of a 99mTc-labeled anti-VEGF peptide targeting neuropilin-1, Nucl. Med. Biol, vol.31, issue.5, pp.575-581, 2004.

A. Starzec, P. Ladam, R. Vassy, S. Badache, N. Bouchemal et al., Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex, Peptides, vol.28, issue.12, pp.2397-2402, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00703415

A. Starzec, R. Vassy, A. Martin, M. Lecouvey, M. D. Benedetto et al., Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1, Life Sci, vol.79, issue.25, pp.2370-2381, 2006.

N. Thomas, L. Tirand, E. Chatelut, F. Plenat, C. Frochot et al., Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma-bearing nude mice, Photochem. Photobiol. Sci. Off. J. Eur. Photochem. Assoc. Eur. Soc. Photobiol, vol.7, issue.4, pp.433-441, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00323709

L. Tirand, C. Frochot, R. Vanderesse, N. Thomas, E. Trinquet et al., A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells, J. Control Release, vol.111, issue.1e2, pp.153-164, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00021947

H. Wu, H. Chen, D. Pan, Y. Ma, S. Liang et al., Imaging integrin alphavbeta 3 and NRP-1 positive gliomas with a novel fluorine-18 labeled RGD-ATWLPPR heterodimeric peptide probe, Mol. Imag. Biol, vol.16, issue.6, pp.781-792, 2014.

K. N. Sugahara, G. B. Braun, T. H. De-mendoza, V. R. Kotamraju, R. P. French et al., Tumor-penetrating iRGD peptide inhibits metastasis, Mol. Canc. Ther, vol.14, issue.1, pp.120-128, 2015.

K. N. Sugahara, T. Teesalu, P. P. Karmali, V. R. Kotamraju, L. Agemy et al., Tissue-penetrating delivery of compounds and nanoparticles into tumors, Canc. cell, vol.16, issue.6, pp.510-520, 2009.

X. Liu, P. Lin, I. Perrett, J. Lin, Y. P. Liao et al., Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer, J. Clin. Invest, vol.127, issue.5, 2017.

L. Roth, C. Prahst, T. Ruckdeschel, S. Savant, S. Westrom et al., Neuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation, Sci. Signal, vol.9, issue.425, p.42, 2016.

S. Xu, B. Z. Olenyuk, C. T. Okamoto, and S. F. Hamm-alvarez, Targeting receptormediated endocytotic pathways with nanoparticles: rationale and advances, vol.65, pp.121-138, 2013.

J. Ciccione, T. Jia, J. Coll, K. Parra, M. Amblard et al., Unambiguous and controlled one-pot synthesis of multifunctional silica nanoparticles, Chem. Mater, vol.28, issue.3, pp.885-889, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01275703

T. Asefa and Z. Tao, Biocompatibility of mesoporous silica nanoparticles, Chem. Res. Toxicol, vol.25, issue.11, pp.2265-2284, 2012.

F. Chen, H. Hong, S. Shi, S. Goel, H. F. Valdovinos et al., Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy, Sci. Rep, vol.4, p.5080, 2014.

Y. Chen, Q. Meng, M. Wu, S. Wang, P. Xu et al., Hollow mesoporous organosilica nanoparticles: a generic intelligent framework-hybridization approach for biomedicine, J. Am. Chem. Soc, vol.136, issue.46, pp.16326-16334, 2014.

M. W. Ambrogio, T. A. Pecorelli, K. Patel, N. M. Khashab, A. Trabolsi et al., Snap-top nanocarriers, vol.12, pp.3304-3307, 2010.

C. De-la-torre, A. Agostini, L. Mondragon, M. Orzaez, F. Sancenon et al., Temperature-controlled release by changes in the secondary structure of peptides anchored onto mesoporous silica supports, Chem. Commun, vol.50, issue.24, pp.3184-3186, 2014.

B. Busser, L. Sancey, V. Josserand, C. Niang, M. C. Favrot et al., Amphiregulin promotes BAX inhibition and resistance to gefitinib in nonsmall-cell lung cancers, Mol. Ther, vol.18, issue.3, pp.528-535, 2010.

A. Karageorgis, S. Dufort, L. Sancey, M. Henry, S. Hirsjarvi et al., An MRI-based classification scheme to predict passive access of 5 to 50-nm large nanoparticles to tumors, Sci. Rep, vol.6, p.21417, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01388813

X. Z. West, N. Meller, N. L. Malinin, L. Deshmukh, J. Meller et al., Integrin beta3 crosstalk with VEGFR accommodating tyrosine phosphorylation as a regulatory switch, PLos One, vol.7, issue.2, p.31071, 2012.

M. Simons, E. Gordon, and L. Claesson-welsh, Mechanisms and regulation of endothelial VEGF receptor signalling, Nat. Rev. Mol. Cell Biol, pp.611-625, 2016.

N. Zoppi, S. Barlati, and M. Colombi, FAK-independent alphavbeta3 integrin-EGFR complexes rescue from anoikis matrix-defective fibroblasts, Biochim. Biophys. Acta, vol.1783, issue.6, pp.1177-1188, 2008.

Z. Liu, L. Han, Y. Dong, Y. Tan, Y. Li et al., EGFRvIII/integrin beta3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis, vol.7, pp.4680-4694, 2016.

P. L. Jones, J. Crack, and M. Rabinovitch, Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth, J. Cell Biol, vol.139, issue.1, pp.279-293, 1997.

S. Rahman, Y. Patel, J. Murray, K. V. Patel, R. Sumathipala et al., Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signalling pathway in endothelial cells, BMC Cell Biol, vol.6, issue.1, p.8, 2005.

K. Vuori and E. Ruoslahti, Association of insulin receptor substrate-1 with integrins, Science, vol.266, issue.5190, pp.1576-1578, 1994.

D. M. Beauvais and A. C. Rapraeger, Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation, J. Cell Sci, vol.123, pp.3796-3807, 2010.

T. Curk, J. Dobnikar, and D. Frenkel, Optimal multivalent targeting of membranes with many distinct receptors, Proc. Natl. Acad. Sci. USA, vol.114, issue.28, pp.7210-7215, 2017.

S. Hirsjarvi, S. Dufort, J. Gravier, I. Texier, Q. Yan et al., Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models, Nanomedicine, vol.9, issue.3, pp.375-387, 2013.

H. Cabral, Y. Matsumoto, K. Mizuno, Q. Chen, M. Murakami et al., Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size, Nat. Nanotechnol, vol.6, issue.12, pp.815-823, 2011.

E. A. Sykes, J. Chen, G. Zheng, and W. C. Chan, Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency, ACS Nano, vol.8, issue.6, pp.5696-5706, 2014.

R. Lasserre, X. J. Guo, F. Conchonaud, Y. Hamon, O. Hawchar et al., Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation, Nat. Chem. Biol, vol.4, issue.9, pp.538-547, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00345908

N. Bettache, L. Baisamy, S. Baghdiguian, B. Payrastre, P. Mangeat et al., Mechanical constraint imposed on plasma membrane through transverse phospholipid imbalance induces reversible actin polymerization via phosphoinositide 3-kinase activation, J. Cell Sci, vol.116, issue.11, pp.2277-2284, 2003.

S. Miyamoto, S. K. Akiyama, and K. M. Yamada, Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function, Science, vol.267, issue.5199, pp.883-885, 1995.

S. N. Voicu, D. Dinu, C. Sima, A. Hermenean, A. Ardelean et al., Silica nanoparticles induce oxidative stress and autophagy but not apoptosis in the MRC-5 cell line, Int. J. Mol. Sci, vol.16, issue.12, pp.29398-29416, 2015.

Y. Yu, J. Duan, Y. Yu, Y. Li, X. Liu et al., Silica nanoparticles induce autophagy and autophagic cell death in HepG2 cells triggered by reactive oxygen species, J. Hazard Mater, vol.270, pp.176-186, 2014.

M. Ahamed, Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells, Hum. Exp. Toxicol, vol.32, issue.2, pp.186-195, 2013.

A. Nemmar, S. Albarwani, S. Beegam, P. Yuvaraju, J. Yasin et al., Amorphous silica nanoparticles impair vascular homeostasis and induce systemic inflammation, Int. J. Nanomed, vol.9, pp.2779-2789, 2014.

J. Duan, Y. Yu, Y. Yu, Y. Li, J. Wang et al., Silica nanoparticles induce autophagy and endothelial dysfunction via the PI3K/Akt/ mTOR signaling pathway, Int. J. Nanomed, vol.9, pp.5131-5141, 2014.

H. Yi, Z. Wang, X. Li, M. Yin, L. Wang et al., Silica nanoparticles target a wnt signal transducer for degradation and impair embryonic development in zebrafish, Theranostics, vol.6, issue.11, pp.1810-1820, 2016.

S. Dufort, L. Sancey, and J. L. Coll, Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution, Adv. Drug Deliv. Rev, vol.64, issue.2, pp.179-189, 2012.

E. Kluza, I. Jacobs, S. J. Hectors, K. H. Mayo, A. W. Griffioen et al., Dual-targeting of alphavbeta3 and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivo, J. Control. release Off. J. Control. Release Soc, vol.158, issue.2, pp.207-214, 2012.

H. Y. Ko, K. J. Choi, C. H. Lee, and S. Kim, A multimodal nanoparticle-based cancer imaging probe simultaneously targeting nucleolin, integrin alphavbeta3 and tenascin-C proteins, Biomaterials, vol.32, issue.4, pp.1130-1138, 2011.